A plethora of positives to take out from this announcement, the CSIRO have increased the yield considerably of Flavocide which will reassure potential partners that this product is commercially viable if they are sitting on the fence.
Bio-Gene also own the IP from this collaboration and manufacturing process.
It seems the market believed Virbac was the only agchem company interested in commercialising Bio-Gene's offerings. I look forward to seeing what partnerships and new collaborations come through this year.
Ann: Manufacturing Project with CSIRO Advances to Stage 3, page-9
Add BGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.859M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 107673 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 12495 | 1 |
View Market Depth
| Last trade - 10.13am 03/12/2024 (20 minute delay) ? |
| BGT (ASX) Chart |
Day chart unavailable
